8-K: NorthView Acquisition Corp. Amends Merger Agreement and Secures $20 Million Convertible Note Financing

Sentiment:

8-K Filing


NorthView Acquisition Corp. revises its merger agreement with Profusa, Inc., extending milestone deadlines and adjusting revenue targets, while also entering into a securities purchase agreement for up to $20 million in convertible notes.

Delay expectedThe document contains details about a delay as the parties extended the period for Profusa to consummate the APAC Joint Venture and receive the related funding from December 31, 2024 until December 31, 2025.The document contains details about a delay as the parties revised the definition of Milestone Event IV to change the earnout revenue target from $99,702,000 for the fiscal year ended December 31, 2025 to an earnout revenue target of $11,864,000 for the fiscal year ended December 31, 2026.
Capital raiseNorthView entered into a securities purchase agreement with an institutional investor for up to $22,222,222 in senior secured convertible promissory notes, with a purchase price of up to $20,000,000 after a 10% original issue discount (OID).The convertible notes will be purchased in multiple tranches, with an initial closing of $10,000,000 in aggregate principal amount ($9,000,000 purchase price) upon consummation of the Business Combination.NorthView may request additional convertible notes up to $12,222,222 prior to the one-year anniversary of the initial closing date, subject to certain conditions, including trading volume and stock price thresholds.The investor may also call from NorthView an additional convertible note having an aggregate principal amount of $4,444,444 at a purchase price of $4,000,000 within 12 months of the Initial Closing.

Summary

  • NorthView Acquisition Corp. has amended its merger agreement with Profusa, Inc., pushing back the deadline for Profusa to consummate the APAC Joint Venture to December 31, 2025, and changing the earnout revenue target for the fiscal year ended December 31, 2025, to $11,864,000 for the fiscal year ended December 31, 2026.
  • The amendment also revises the Company Reference Value to account for financing proceeds received by Profusa before the Business Combination, debt conversions, and incentive shares to be issued.
  • Concurrently, NorthView entered into a securities purchase agreement with an institutional investor for up to $22,222,222 in senior secured convertible promissory notes, with a purchase price of up to $20,000,000 after a 10% original issue discount (OID).
  • The convertible notes will be purchased in multiple tranches, with an initial closing of $10,000,000 in aggregate principal amount ($9,000,000 purchase price) upon consummation of the Business Combination.
  • NorthView may request additional convertible notes up to $12,222,222 prior to the one-year anniversary of the initial closing date, subject to certain conditions, including trading volume and stock price thresholds.
  • The investor may also call from NorthView an additional convertible note having an aggregate principal amount of $4,444,444 at a purchase price of $4,000,000 within 12 months of the Initial Closing.
  • Each convertible note will mature 18 months from its respective closing date and is convertible at the lower of $10 or 95% of the lowest daily volume-weighted average price per share of New Profusa Common Stock in the 10 trading days prior to the original issue date.
  • Interest accrues at 10% per annum, increasing to 24% upon an event of default, with a 5% fee on cash payments.
  • Certain holders of NorthView common stock, including officers and directors, will enter into lock-up agreements restricting the sale of their shares from the Initial Closing Date until the termination of the Lock-Up Agreement.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While the amendment and financing provide necessary capital and flexibility, the delays and dilution associated with the convertible notes temper the overall outlook.

Positives

  • Securing up to $20 million in convertible note financing provides additional capital for the combined company.
  • Extending the APAC Joint Venture deadline offers more time for Profusa to achieve this milestone.
  • Revising the earnout revenue target to a later date may be more realistic and achievable.
  • The lock-up agreements provide stability by restricting the sale of shares by key holders.

Negatives

  • The convertible notes dilute existing shareholders upon conversion.
  • The 10% OID reduces the actual capital received from the convertible note financing.
  • The 24% default interest rate could be burdensome if the company experiences financial difficulties.
  • The lock-up agreements may limit liquidity for certain shareholders.

Risks

  • Failure to consummate the Business Combination could impact the initial closing of the convertible note financing.
  • The company may not be able to meet the trading volume and stock price thresholds required to access additional tranches of the convertible notes.
  • The company may not be able to generate sufficient revenue to meet the revised earnout target.
  • The company may default on the convertible notes, triggering the higher interest rate and potential legal action.
  • The company may be unable to obtain stockholder approval for issuances of shares of Common Stock in excess of the Exchange Cap.

Future Outlook

The document contains forward-looking statements regarding the anticipated benefits of the proposed transaction, the combined company becoming a publicly listed company, the anticipated impact of the proposed transaction on the combined companies business and future financial and operating results, the anticipated timing of closing of the proposed transaction, the success and customer acceptance of Profusas product and service offerings, and other aspects of Profusas operations or operating results.

Industry Context

This announcement reflects a common strategy for SPACs to secure additional funding and adjust merger terms as they navigate the complex process of completing business combinations. The extension of milestone deadlines and revision of revenue targets suggest a need to adapt to evolving market conditions or unforeseen challenges in the target company's business.

Comparison to Industry Standards

  • Comparable companies in the SPAC market often utilize convertible notes to bridge financing gaps before or after a merger.
  • The terms of the convertible notes, such as the OID and interest rate, are generally within the range observed in similar transactions.
  • The lock-up agreements are standard practice to ensure stability and prevent significant stock sales immediately following the merger.
  • The milestone extensions and revenue target adjustments are not uncommon in SPAC mergers, as companies may need to revise their projections based on market dynamics or operational factors.
  • Comparable companies include Digital World Acquisition Corp. which also had a merger agreement and convertible note financing.
  • Another comparable company is Gores Guggenheim, Inc. which also had a merger agreement and convertible note financing.

Stakeholder Impact

  • Shareholders will experience dilution upon conversion of the convertible notes.
  • Employees may benefit from the additional capital and extended timeline for the Business Combination.
  • Customers may see continued product development and service offerings from Profusa.
  • Suppliers may experience continued business relationships with the combined company.
  • Creditors may be impacted by the new convertible note financing and its priority in the capital structure.

Next Steps

  • Obtain stockholder approval for the Business Combination.
  • Satisfy the conditions for the initial closing of the convertible note financing.
  • Meet the trading volume and stock price thresholds to access additional tranches of the convertible notes.
  • Achieve the revised earnout revenue target for the fiscal year ended December 31, 2026.
  • Comply with the terms of the lock-up agreements.

Key Dates

DateDescription
2022-11-07Original Merger Agreement and Plan of Reorganization date
2023-09-12Amendment No. 1 to Merger Agreement date
2024-01-12Amendment No. 2 to Merger Agreement date
2024-02-26NorthView's Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC
2024-03-04Amendment No. 3 to Merger Agreement date
2024-12-31Original deadline for Profusa to consummate the APAC Joint Venture
2025-02-11Amendment No. 4 to Merger Agreement and Securities Purchase Agreement date
2025-12-31Revised deadline for Profusa to consummate the APAC Joint Venture
2026-12-31Revised earnout revenue target date

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.